SK282506B6 - Tableta obsahujúca paracetamol a domperidon - Google Patents

Tableta obsahujúca paracetamol a domperidon Download PDF

Info

Publication number
SK282506B6
SK282506B6 SK1032-96A SK103296A SK282506B6 SK 282506 B6 SK282506 B6 SK 282506B6 SK 103296 A SK103296 A SK 103296A SK 282506 B6 SK282506 B6 SK 282506B6
Authority
SK
Slovakia
Prior art keywords
domperidone
paracetamol
tablet
agents
tablets
Prior art date
Application number
SK1032-96A
Other languages
English (en)
Slovak (sk)
Other versions
SK103296A3 (en
Inventor
Gordon Prudhoe
Original Assignee
Janssen Pharmaceutica N. V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8216670&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK282506(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica N. V. filed Critical Janssen Pharmaceutica N. V.
Publication of SK103296A3 publication Critical patent/SK103296A3/sk
Publication of SK282506B6 publication Critical patent/SK282506B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK1032-96A 1994-02-28 1995-02-27 Tableta obsahujúca paracetamol a domperidon SK282506B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94200498 1994-02-28
PCT/EP1995/000719 WO1995022974A2 (en) 1994-02-28 1995-02-27 Film coated tablet of paracetamol and domperidone

Publications (2)

Publication Number Publication Date
SK103296A3 SK103296A3 (en) 1997-03-05
SK282506B6 true SK282506B6 (sk) 2002-10-08

Family

ID=8216670

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1032-96A SK282506B6 (sk) 1994-02-28 1995-02-27 Tableta obsahujúca paracetamol a domperidon

Country Status (30)

Country Link
US (1) US5814339A (ja)
EP (1) EP0749308B1 (ja)
JP (1) JP2931409B2 (ja)
KR (1) KR100202154B1 (ja)
CN (1) CN1084616C (ja)
AT (1) ATE240102T1 (ja)
AU (1) AU703242B2 (ja)
BR (1) BR9506903A (ja)
CA (1) CA2182004C (ja)
CY (1) CY2383B1 (ja)
CZ (1) CZ291999B6 (ja)
DE (1) DE69530759T2 (ja)
DK (1) DK0749308T3 (ja)
ES (1) ES2199982T3 (ja)
FI (1) FI117373B (ja)
HK (1) HK1010687A1 (ja)
HU (1) HU228149B1 (ja)
IL (1) IL112802A (ja)
MX (1) MX9603690A (ja)
MY (1) MY115433A (ja)
NO (1) NO309455B1 (ja)
NZ (1) NZ281236A (ja)
PL (1) PL179080B1 (ja)
PT (1) PT749308E (ja)
RU (1) RU2153337C2 (ja)
SI (1) SI0749308T1 (ja)
SK (1) SK282506B6 (ja)
TW (1) TW466119B (ja)
WO (1) WO1995022974A2 (ja)
ZA (1) ZA951616B (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9710767D0 (en) * 1996-06-26 1997-07-23 On Ninh Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same
GB9816899D0 (en) 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
GB2443793B (en) * 2006-04-05 2010-12-01 Reckitt Benckiser Healthcare Product, method of manufacture and use
WO2008134540A1 (en) * 2007-04-26 2008-11-06 Aronchick Craig A Compositions and methods for transmucosal delivery of domperidone
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
CN101842085B (zh) 2007-10-31 2013-01-30 麦克内尔-Ppc股份有限公司 口腔崩解剂型
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US20110070301A1 (en) * 2009-09-24 2011-03-24 Luber Joseph R Orally transformable tablets
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
FR2992218B1 (fr) * 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN106068120B (zh) 2014-01-10 2021-03-23 强生消费者公司 使用射频和有损耗的包衣粒子制造片剂的方法
CN108697700B (zh) * 2016-02-04 2021-08-17 辛多美制药有限公司 氘代多潘立酮组合物和用于治疗病症的方法
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
US11364226B2 (en) 2017-06-30 2022-06-21 Cinrx Pharma, Llc Deuterated domperidone compositions, methods, and preparation
CN110302169A (zh) * 2019-08-01 2019-10-08 张慧芬 一种滑膜衣片剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
CA2020018A1 (en) * 1990-06-27 1991-12-28 Don L. Simmons Method and composition for treating the migraine complex
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
JPH08502032A (ja) * 1992-07-07 1996-03-05 セプラコア インコーポレーテッド 胃食道逆流疾患およびその他の障害を治療するために▲（−）▼シサプリドを使用する方法
TW272942B (ja) * 1993-02-10 1996-03-21 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
DE69530759T2 (de) 2004-03-18
TW466119B (en) 2001-12-01
EP0749308B1 (en) 2003-05-14
AU703242B2 (en) 1999-03-25
CZ225596A3 (en) 1996-11-13
NO309455B1 (no) 2001-02-05
MY115433A (en) 2003-06-30
WO1995022974A3 (en) 1995-09-21
JP2931409B2 (ja) 1999-08-09
IL112802A (en) 1999-08-17
JPH09500910A (ja) 1997-01-28
MX9603690A (es) 1997-06-28
PT749308E (pt) 2003-10-31
CN1084616C (zh) 2002-05-15
FI117373B (fi) 2006-09-29
CY2383B1 (en) 2004-06-04
NO962153D0 (no) 1996-05-28
BR9506903A (pt) 1997-09-09
CA2182004A1 (en) 1995-08-31
HUT74477A (en) 1996-12-30
PL179080B1 (pl) 2000-07-31
CN1141589A (zh) 1997-01-29
HU228149B1 (en) 2012-12-28
US5814339A (en) 1998-09-29
FI962156A0 (fi) 1996-05-22
IL112802A0 (en) 1995-05-26
AU1812395A (en) 1995-09-11
NO962153L (no) 1996-08-26
SK103296A3 (en) 1997-03-05
CZ291999B6 (cs) 2003-07-16
FI962156A (fi) 1996-06-04
ES2199982T3 (es) 2004-03-01
DK0749308T3 (da) 2003-09-01
ZA951616B (en) 1996-08-27
HU9601384D0 (en) 1996-07-29
CA2182004C (en) 2000-10-31
WO1995022974A2 (en) 1995-08-31
EP0749308A1 (en) 1996-12-27
ATE240102T1 (de) 2003-05-15
RU2153337C2 (ru) 2000-07-27
SI0749308T1 (en) 2003-10-31
NZ281236A (en) 2001-11-30
PL314850A1 (en) 1996-09-30
HK1010687A1 (en) 1999-06-25
KR100202154B1 (ko) 1999-06-15
DE69530759D1 (de) 2003-06-18

Similar Documents

Publication Publication Date Title
SK282506B6 (sk) Tableta obsahujúca paracetamol a domperidon
CN1119993C (zh) 醋氨酚、假麻黄碱、扑尔敏和可有可无的美沙芬的旋转制粒及包衣
KR101445757B1 (ko) 옥시코돈을 포함하는 과립 및 경구 붕해 정제
US20040131671A1 (en) Sustained release formulations containing acetaminophen and tramadol
PT758235E (pt) Comprimido revestido com polimero compreendendo amoxicilina e clavulanato
WO2000030647A1 (en) Compositions comprising cefuroxime axetil
KR20040007665A (ko) 파라세타몰을 포함하는 연하 정제
US20060159751A1 (en) Controlled release pharmaceutical compositions of carbidopa and levodopa
US20060002997A1 (en) Nitrofurantoin controlled release dosage form
EP2010158B1 (en) Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
KR20100016295A (ko) 클로피도그렐 바이설페이트의 안정한 약학적 조성물 및 그의 제조 방법
UA79567C2 (en) Orodispersible pharmaceutical composition of antithrombolic compound
JP4824224B2 (ja) 糖衣製剤
CA2482114C (en) Solid dosage form comprising caffeine
EP3900708A1 (en) Extended-release medical composition containing zaltoprofen
WO2022184981A1 (en) Stable pharmaceutical compositions of metformin
US20040228918A1 (en) Granule modulating hydrogel system
RU98111607A (ru) Фармацевтические готовые формы

Legal Events

Date Code Title Description
MK4A Expiry of patent

Expiry date: 20150227